Genetically modified bacillus subtilis strain and use as a live delivery and production system
US-2024390433-A1 · Nov 28, 2024 · US
US9200288B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9200288-B2 |
| Application number | US-201113639487-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 27, 2011 |
| Priority date | Apr 27, 2010 |
| Publication date | Dec 1, 2015 |
| Grant date | Dec 1, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are metabolically-modified microorganisms useful for producing 1,4-butanediol.
Opening claim text (preview).
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A recombinant prokaryotic microorganism metabolically engineered from a parental prokaryotic microorganism to produce 1,4-butanediol, said recombinant prokaryotic microorganism comprising genes encoding the following: a. a xylonate dehydrogenase that catalyzes the conversion of xylose to xylonic acid, wherein said xylonate dehydrogenase comprises an amino acid sequenc…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.